


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-2.62%
-0.92%
+1.09%
-11.46%
SYK
Stryker
$369.56
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
Risk Analysis

Trading above its fair value
SYK Price Performance
$348.79 (+5.95%)
$357.67 (+3.32%)
$377.11 (-2.00%)
$385.61 (-4.16%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY

Eps growth
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading above its fair value

Outperform the market
![]()
SYK Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SYK Street Sentiment is extremely bullish and have positive views on the near-term outlook
SYK has Low risk level

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Jan 06, 2026
Upgrade
Outperform
Raymond James
Dec 22, 2025
Reiterate
Buy
Citi
Dec 19, 2025
Reiterate
Hold
Truist Securities
Dec 12, 2025
Reiterate
Buy
Citigroup
Nov 15, 2025
Reiterate
Hold
Truist Securities
SYK
Stryker
369.56
+4.27%
MMSI
Merit Medical System
81.09
+1.06%
BTCS
BTCS
2.24
-11.46%
MOLN
Molecular Partners AG
4.25
+2.29%
ANET
Arista Networks
141.74
-4.36%
What is SYK current stock price?
What are SYK stock strengths?
What is SYK Risk Level?
What is SYK market cap and volume?
What is SYK current Stock IQ?
Should I buy SYK stock right now?
Is SYK a Strong Buy right now?
What does a 'Strong Buy' rating mean for SYK?
What does a 'Strong Sell' rating mean for SYK?
What factors influence SYK's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-2.62%
-0.92%
+1.09%
-11.46%
SYK
Stryker
Current Price
$369.56
Recently Viewed
SYK
Stryker
369.56
+4.27%
MMSI
Merit Medical System
81.09
+1.06%
BTCS
BTCS
2.24
-11.46%
MOLN
Molecular Partners AG
4.25
+2.29%
ANET
Arista Networks
141.74
-4.36%

SYK Price Performance
$348.79 (+5.95%)
$357.67 (+3.32%)
$377.11 (-2.00%)
$385.61 (-4.16%)
SYK Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Earnings increase YoY

Eps growth
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading above its fair value

Outperform the market
![]()
SYK Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
SYK Street Sentiment is extremely bullish and have positive views on the near-term outlook
SYK has Low risk level

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Jan 06, 2026
Upgrade
Outperform
Raymond James
Dec 22, 2025
Reiterate
Buy
Citi
Dec 19, 2025
Reiterate
Hold
Truist Securities
Dec 12, 2025
Reiterate
Buy
Citigroup
Nov 15, 2025
Reiterate
Hold
Truist Securities
Nov 15, 2025
Reiterate
Overweight
Wells Fargo
SYK Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Outperform the market
Risk Analysis

Trading above its fair value
SYK Latest Analysis
Stryker projects 8%–9.5% organic sales growth for 2026 while advancing margin expansion and new product launches.
Fri Jan 30, 2026
Stryker (SYK) Surpasses Q4 Earnings and Revenue Estimates. Stryker (SYK) delivered earnings and revenue surprises of 1.71% and 0.61% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Thu Jan 29, 2026
Stryker raises annual profit forecast on strong sales for medical devices.
Thu Jan 29, 2026
Stryker Corp. Q4 Profit Rises . (RTTNews) - Stryker Corp. (SYK) announced earnings for its fourth quarter that Increases from the same period last year
Thu Jan 29, 2026
Stryker Non-GAAP EPS of $4.47 beats by $0.07 revenue of $7.2B beats by $80M.
Thu Jan 29, 2026
Stryker Q4 results beat on both lines. 2026 EPS guidance includes consensus.
Thu Jan 29, 2026
A Preview Of Strykers Earnings. Stryker (NYSE:) is gearing up to announce its quarterly earnings on Thursday 2026-01-29. Here'.s a quick overview of what investors should know before the release.Analysts are estimating that Stryker will report an The announcement from Stryker is eagerly anticipated with investors seeking news of surpassing estimates and favorable guidance for the next quarter.It'.s worth noting for new investors that guidance can be a key determinant of stock price movem
Wed Jan 28, 2026
SYKs Q4 Results Likely to Reflect Procedure Growth and Capital Demand. Strykers fourth-quarter results are expected to highlight resilient procedure volumes and strong capital demand supported by product momentum and broad-based strength.
Wed Jan 28, 2026
Strategy To YieldBoost Stryker To 8.4% Using Options. Shareholders of Stryker Corp (Symbol: SYK) looking to boost their income beyond the stocks 1% annualized dividend yield can sell the December covered call at the $380 strike and collect the premium based on the $23.50 bid which annualizes to an additional 7.4% rate of return a
Tue Jan 27, 2026
Gear Up for Stryker (SYK) Q4 Earnings: Wall Street Estimates for Key Metrics. Besides Wall Streets top-and-bottom-line estimates for Stryker (SYK) review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2025.
Mon Jan 26, 2026
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.